Stay updated on Esketamine Safety in Treatment-Resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page.

Latest updates to the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page
- Check5 days agoChange DetectedThe page history adds a new site revision entry 'Revision: v3.3.3' and removes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedThe government funding notice was removed, affecting only ancillary guidance; otherwise the study record history and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check56 days agoChange DetectedThe new screenshot shows an expanded version history with more entries and a revised header, while the core study content remains unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference8%

- Check91 days agoChange DetectedUpdated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new software release.SummaryDifference0.2%

Stay in the know with updates to Esketamine Safety in Treatment-Resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page.